Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-dependent RNA helicase DDX19B is a member of the DEAD-box protein family characterized by the conserved motif "Asp-Glu-Ala-Asp" (DEAD). It functions as an RNA helicase with ATPase activity and is involved in numerous RNA metabolic processes, particularly the export of mRNA from the nucleus to the cytoplasm. Rather than unwinding RNA duplexes in a classical sense, DDX19B remodels ribonucleoprotein particles by displacing proteins from nuclear mRNA and facilitating the loading of cytoplasmic mRNA-binding proteins. This process is essential for the regulated trafficking and maturation of mRNAs. DDX19B is recruited to the cytoplasmic fibrils of the nuclear pore complex and plays a crucial role in translation initiation, pre-mRNA splicing, ribosome assembly, and possibly other aspects of RNA metabolism. Dysfunction or altered expression of DDX19B may contribute to disease, most notably certain cancers, though the evidence for this is currently limited
ATP-dependent RNA unwinding Remodeling of ribonucleoprotein particles (RNPs), facilitating the replacement of nuclear mRNA-binding proteins with cytoplasmic ones during export
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-dependent RNA helicase DDX19B (DDX19B).